You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
SODIUM FRACT EXCRET |
||
Geisinger Epic Procedure Code: LAB3469
Geisinger Epic ID: 23482
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Serum OR plasma* AND random urine | |
Preferred collection container: |
||
Specimen required: |
2 mL aliquot serum or plasma; 5 mL urine. Collection of serum and urine specimens must be within 8 hours. | |
Special notes: |
*Lithium heparin plasma is acceptable from in-house collection. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection. | |
Transport temperature: |
Refrigerated. | |
Specimen stability: |
See individual member listing. | |
Rejection criteria: |
Serum (or plasma) and urine specimens collected more than 8 hours apart are not acceptable. | |
TEST DETAILS |
||
Interpretation guide: |
Fractional excretion of sodium (FeNa) should only be used in the setting of AKI. For patients with AKI: <1% suggestive of prerenal disease such as true volume depletion or decreased effective circulating volume (heart failure, cirrhosis). Can also be seen in acute glomerulonephritis, contrast nephropathy, or pigment nephropathy. 1-2% non-diagnostic >2% suggestive of ATN Considerations: FeNa can be falsely elevated in patients with CKD or on diuretics. For patients on diuretics, the fractional excretion of urea (FEUrea) is preferred. |
|
CPT code(s): |
84295, 82565, 82570, 84300 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Urine sodium, urine creatinine, serum sodium, serum creatinine. | |
Methodology: |
Potentiometric Spectrophotometric (Colorimetric) |
|
Synonyms: |
SODIUM FRACTIONAL EXCRETION
|
|
Clinical significance: |
This test can aid in the differentiation of prerenal disease and acute tubular necrosis (ATN). | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |